Hairstyles Yulia Vitalievna

Hairstyles Yulia Vitalievna

Career

2010

Strizhak began her professional career in the pharmaceutical industry in 2010 in the over-the-counter drugs division of GSK after nine years in FMCG companies. During her time at GSK, she held various positions in sales and marketing, and also led the integration of the portfolios of over-the-counter and consumer goods of GSK and Novartis.

2017-2019

In 2017, Strizhak moved to the prescription drug division GSK as commercial director. In 2019, she headed the business unit of innovative respiratory drugs.

2023: Appointment as CEO of GSK in Russia

In mid-April 2023, the British pharmaceutical company GlaxoSmithKline (GSK) announced the change of the CEO of the Russian representative office. They appointed Julia Strizhak instead of Michael John Riley.

I and our entire team will continue to work, focusing on ensuring that patients in Russia are provided with access to the necessary drugs and vaccines of our company, - said Strizhak, whose words are quoted by the press service of the Russian subsidiary GSK.

The reason for the change of the head of the GSK business in the Russian Federation is not called. At the same time, at the end of 2022, it became known about the reduction in the number of personnel in the Russian office of the company. Then the employees were offered to quit with compensation. The press service of the company reported that the operating model in the country is changing and all promotion activities have been stopped. In this regard, the issue of voluntary termination of labor relations by agreement of the parties is being discussed.

In 2022, GSK refused to supply vitamins and dietary supplements to Russia. At the same time, then the company assured that they would continue to supply vaccines and drugs to the country and would solve logistics problems.^[1]

Notes